ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
Magomed Ankalaev’s victory over Alex Pereira at UFC 313 seemingly disrupted the potential superfight between the Brazilian ...
The prevalence of performance-enhancing drugs (PEDs) in MMA has become an escalating concern within the fighter community.
New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.
Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.
India Today on MSN3d
Struggling to conceive? How endometriosis may be affecting your fertilityEndometriosis is a long-term illness in which tissue that resembles the endometrial lining of the uterus grows elsewhere in ...
The National on MSN3d
Changing the fertility conversation: UAE experts on what to know about reproductive healthHow do we talk about the rise of infertility without creating anxiety? When is it appropriate to broach topics such as egg ...
Trial 4: A multinational European trial comparing sorafenib-plus-docetaxel or -letrozole versus docetaxel- or letrozole-plus-placebo as first-line therapy in patients with MBC. Potential trials ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback